Lack of Boxed Warnings
Custom-compounded hormone products may not contain package labeling or the boxed warning about increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary embolism, and deep vein thrombosis that all FDAapproved estrogens must provide.